Literature DB >> 23578464

Recent progress in nanomedicine: therapeutic, diagnostic and theranostic applications.

Larissa Y Rizzo1, Benjamin Theek, Gert Storm, Fabian Kiessling, Twan Lammers.   

Abstract

In recent years, the use of nanomedicine formulations for therapeutic and diagnostic applications has increased exponentially. Many different systems and strategies have been developed for drug targeting to pathological sites, as well as for visualizing and quantifying important (patho-) physiological processes. In addition, ever more efforts have been undertaken to combine diagnostic and therapeutic properties within a single nanomedicine formulation. These so-called nanotheranostics are able to provide valuable information on drug delivery, drug release and drug efficacy, and they are considered to be highly useful for personalizing nanomedicine-based (chemo-) therapeutic interventions.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23578464      PMCID: PMC3833836          DOI: 10.1016/j.copbio.2013.02.020

Source DB:  PubMed          Journal:  Curr Opin Biotechnol        ISSN: 0958-1669            Impact factor:   9.740


  49 in total

1.  Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy.

Authors:  Nagesh Kolishetti; Shanta Dhar; Pedro M Valencia; Lucy Q Lin; Rohit Karnik; Stephen J Lippard; Robert Langer; Omid C Farokhzad
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-04       Impact factor: 11.205

Review 2.  Nanomedicine.

Authors:  Betty Y S Kim; James T Rutka; Warren C W Chan
Journal:  N Engl J Med       Date:  2010-12-16       Impact factor: 91.245

3.  Tracking neural stem cells in patients with brain trauma.

Authors:  Jianhong Zhu; Liangfu Zhou; FengGe XingWu
Journal:  N Engl J Med       Date:  2006-11-30       Impact factor: 91.245

4.  First-in-man study of CPX-351: a liposomal carrier containing cytarabine and daunorubicin in a fixed 5:1 molar ratio for the treatment of relapsed and refractory acute myeloid leukemia.

Authors:  Eric J Feldman; Jeffrey E Lancet; Jonathan E Kolitz; Ellen K Ritchie; Gail J Roboz; Alan F List; Steven L Allen; Ekatherine Asatiani; Lawrence D Mayer; Christine Swenson; Arthur C Louie
Journal:  J Clin Oncol       Date:  2011-01-31       Impact factor: 44.544

5.  Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models.

Authors:  Dmitri B Kirpotin; Daryl C Drummond; Yi Shao; M Refaat Shalaby; Keelung Hong; Ulrik B Nielsen; James D Marks; Christopher C Benz; John W Park
Journal:  Cancer Res       Date:  2006-07-01       Impact factor: 12.701

Review 6.  Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress.

Authors:  Twan Lammers; Fabian Kiessling; Wim E Hennink; Gert Storm
Journal:  J Control Release       Date:  2011-09-16       Impact factor: 9.776

7.  Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy.

Authors:  I Jolanda M de Vries; W Joost Lesterhuis; Jelle O Barentsz; Pauline Verdijk; J Han van Krieken; Otto C Boerman; Wim J G Oyen; Johannes J Bonenkamp; Jan B Boezeman; Gosse J Adema; Jeff W M Bulte; Tom W J Scheenen; Cornelis J A Punt; Arend Heerschap; Carl G Figdor
Journal:  Nat Biotechnol       Date:  2005-10-30       Impact factor: 54.908

Review 8.  Nanocarriers as an emerging platform for cancer therapy.

Authors:  Dan Peer; Jeffrey M Karp; Seungpyo Hong; Omid C Farokhzad; Rimona Margalit; Robert Langer
Journal:  Nat Nanotechnol       Date:  2007-12       Impact factor: 39.213

9.  A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.

Authors:  Y Matsumura; H Maeda
Journal:  Cancer Res       Date:  1986-12       Impact factor: 12.701

Review 10.  Tumour-targeted nanomedicines: principles and practice.

Authors:  T Lammers; W E Hennink; G Storm
Journal:  Br J Cancer       Date:  2008-07-22       Impact factor: 7.640

View more
  67 in total

Review 1.  The evolving landscape of drug products containing nanomaterials in the United States.

Authors:  Sheetal R D'Mello; Celia N Cruz; Mei-Ling Chen; Mamta Kapoor; Sau L Lee; Katherine M Tyner
Journal:  Nat Nanotechnol       Date:  2017-04-24       Impact factor: 39.213

2.  Development and Application of a Novel Model System to Study "Active" and "Passive" Tumor Targeting.

Authors:  Amarnath Mukherjee; Binod Kumar; Koji Hatano; Luisa M Russell; Bruce J Trock; Peter C Searson; Alan K Meeker; Martin G Pomper; Shawn E Lupold
Journal:  Mol Cancer Ther       Date:  2016-08-02       Impact factor: 6.261

Review 3.  Assessing the barriers to image-guided drug delivery.

Authors:  Gregory M Lanza; Chrit Moonen; James R Baker; Esther Chang; Zheng Cheng; Piotr Grodzinski; Katherine Ferrara; Kullervo Hynynen; Gary Kelloff; Yong-Eun Koo Lee; Anil K Patri; David Sept; Jan E Schnitzer; Bradford J Wood; Miqin Zhang; Gang Zheng; Keyvan Farahani
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2013-10-31

4.  Stearic Acid-Grafted Chitooligosaccharide Nanomicelle System with Biocleavable Gadolinium Chelates as a Multifunctional Agent for Tumor Imaging and Drug Delivery.

Authors:  Chuhua Xin; Xiuzhong Yao; Bin Du; Weiyu Yang; Liuguo Wang; Lirong Ma; Weiyu Weng
Journal:  Pharm Res       Date:  2018-11-08       Impact factor: 4.200

5.  Targeted noninvasive imaging of EGFR-expressing orthotopic pancreatic cancer using multispectral optoacoustic tomography.

Authors:  Shanice V Hudson; Justin S Huang; Wenyuan Yin; Sabrin Albeituni; Jamie Rush; Anil Khanal; Jun Yan; Brian P Ceresa; Hermann B Frieboes; Lacey R McNally
Journal:  Cancer Res       Date:  2014-09-12       Impact factor: 12.701

6.  α-Tocopheryl succinate-based amphiphilic block copolymers obtained by RAFT and their nanoparticles for the treatment of cancer.

Authors:  Raquel Palao-Suay; María Rosa Aguilar; Francisco J Parra-Ruiz; Samarendra Maji; Richard Hoogenboom; N A Rohner; Susan N Thomas; Julio San Román
Journal:  Polym Chem       Date:  2015-11-27       Impact factor: 5.582

7.  Excimer Emission of Acridine Orange Adsorbed on Gadolinium-Yttrium Orthovanadate Nanoparticles.

Authors:  K O Hubenko; S L Yefimova; T N Tkacheva; P O Maksimchuk; O O Sedyh; O G Viagin; A V Sorokin; Yu V Malyukin
Journal:  J Fluoresc       Date:  2018-06-30       Impact factor: 2.217

8.  Tailoring the lipid composition of nanoparticles modulates their cellular uptake and affects the viability of triple negative breast cancer cells.

Authors:  Hanan Abumanhal-Masarweh; Dana da Silva; Maria Poley; Assaf Zinger; Evgenya Goldman; Nitzan Krinsky; Ron Kleiner; Gal Shenbach; Josh E Schroeder; Jeny Shklover; Janna Shainsky-Roitman; Avi Schroeder
Journal:  J Control Release       Date:  2019-06-22       Impact factor: 9.776

9.  Citric Juice-mediated Synthesis of Tellurium Nanoparticles with Antimicrobial and Anticancer Properties.

Authors:  David Medina Cruz; William Tien-Street; Bohan Zhang; Xinjing Huang; Ada Vernet Crua; Alfonso Nieto-Argüello; Jorge L Cholula-Díaz; Lidia Martínez; Yves Huttel; María Ujué González; José Miguel García-Martín; Thomas J Webster
Journal:  Green Chem       Date:  2019-03-11       Impact factor: 10.182

10.  Co-encapsulating CoFe2O4 and MTX for hyperthermia.

Authors:  Nada Saleh; Naveed Ahmed; Muhammad Imran Asad; Iqra Chaudhery; Nasir Mahmoud Ahmad
Journal:  IET Nanobiotechnol       Date:  2020-02       Impact factor: 1.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.